Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment
Dal Yong Kim, Dae Ho Lee, Sun-Joo Jang, Sang-We Kim, Cheolwon Suh, Jung Shin Lee
Cancer Res Treat. 2011;43(4):212-216. Published online 2011 Dec 27 DOI: https://doi.org/10.4143/crt.2011.43.4.212
Citations to this article as recorded by 
Docetaxel Nanotechnology in Anticancer Therapy
Pengxiang Zhao, Didier Astruc
ChemMedChem.2012; 7(6): 952. CrossRef